Adverse Events Following Infusion of T Cells for Adoptive Immunotherapy: A 10 Year Experience

BACKGROUND: The FDA currently recommends at least 4 hours of recipient monitoring to detect early infusion reactions; recent catastrophic reactions to “first in man” biological agents have emphasized the importance of this rule for initial studies of new products. The value of such monitoring for be...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Cruz, Conrad Russell, Hanley, Patrick J., Liu, Hao, Torrano, Vicky, Lin, Yu-Feng, Arce, James A., Gottschalk, Stephen, Savoldo, Barbara, Dotti, Gianpietro, Louis, Chrystal U., Leen, Ann M., Gee, Adrian P., Rooney, Cliona M., Brenner, Malcolm K., Bollard, Catherine M., Heslop, Helen E.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2010
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2914831/
https://ncbi.nlm.nih.gov/pubmed/20429793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14653241003709686
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन